The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2020 | Updates from the ERIC Assembly
Paolo Ghia, MD, of the Università Vita-Salute San Raffaele, Milan, Italy, discusses updates from the first virtual ERIC assembly (European Research Initiative on CLL), including a study investigating whether chronic lymphocytic leukemia patients are more severely affected by COVID-19. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
